Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD

Conclusion: Natural product andrographolide inhibited the NLRP3 inflammasome activation in COPD and might be a potential strategy to target COPD excerbations.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Xiao, W., Fu, J.-J., Wang, S.-J., Wang, Y., Miao, T.-W., Mao, B. Tags: Airway pharmacology and treatment Source Type: research